FLT3 gene mutation

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Kinase inhibitor 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Hellenic Society Of Hematology Academic
    GILTERITINIB
    2025-521875-30-00 1 country 2026 n=58 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Hellenic Society Of Hematology Academic 1 Phase II 1
New trials by year
2026
1
← All indication landscapes